DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ADIPEX-P
02 1AGRYLIN
03 5AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
04 1AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
05 1AMOXICILLIN
06 1ANAGRELIDE HYDROCHLORIDE
07 1BROMOCRIPTINE MESYLATE
08 2CEPHALEXIN
09 3CHLORDIAZEPOXIDE HYDROCHLORIDE
10 1CLINDAMYCIN HYDROCHLORIDE
11 1CRIXIVAN
12 1DICYCLOMINE HYDROCHLORIDE
13 1DIPHENHYDRAMINE HYDROCHLORIDE
14 1DOXYCYCLINE
15 2DOXYCYCLINE HYCLATE
16 1EXTENDED PHENYTOIN SODIUM
17 1GABAPENTIN
18 1HEXALEN
19 1HYDROXYUREA
20 2HYDROXYZINE PAMOATE
21 1ISRADIPINE
22 2LENALIDOMIDE
23 6LOXAPINE SUCCINATE
24 1MITIGARE
25 1NITROFURANTOIN
26 1NIZATIDINE
27 2OXYCODONE HYDROCHLORIDE
28 2PHENTERMINE HYDROCHLORIDE
29 4PRAZOSIN HYDROCHLORIDE
30 1RAMIPRIL
31 1SELEGILINE HYDROCHLORIDE
32 3STAVUDINE
33 7TACROLIMUS
34 2TEMAZEPAM
35 1TEMODAR
36 8TEMOZOLOMIDE
37 1TERAZOSIN HYDROCHLORIDE
38 1TETRACYCLINE HYDROCHLORIDE
39 2TIZANIDINE HYDROCHLORIDE
40 2TRIAMTERENE AND HYDROCHLOROTHIAZIDE
41 2ZALEPLON
42 1ZANAFLEX
43 2ZIPRASIDONE HYDROCHLORIDE
44 1ZONISAMIDE
01 119926
02 120333
03 120685
04 121029
05 121447
06 140319
07 161926
08 162500
09 162676
10 162713
11 162752
12 163083
13 171456
14 171457
15 171745
16 171994
17 171995
18 172062
19 172204
20 172205
21 172206
22 173191
23 174821
24 174967
25 175140
26 175321
27 175806
28 176468
29 176762
30 177226
31 177237
32 177238
33 177317
34 177375
35 177470
36 177562
37 177565
38 177637
39 177672
40 177890
41 278466
42 178879
43 178957
44 179047
45 179069
46 180738
47 183116
48 184768
49 184769
50 187022
51 188023
52 188487
53 188496
54 190364
55 190402
56 190596
57 190695
58 190802
59 190836
60 190858
61 191359
62 191502
63 1200534
64 1202778
65 1203490
66 1203740
67 1203898
68 1204639
69 1204752
70 1204820
71 1205227
72 1206309
73 1206413
74 1206651
75 1207658
76 1209605
77 1210435
78 1210971
79 1212297
80 1213112
81 1213438
82 1213834
83 1214618
01 83No
02 1Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : ZIPRASIDONE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77565
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : DOXYCYCLINE
Dosage Form : CAPSULE; ORAL
Application Number : 202778
Country : US
Patented : No
Drug : HEXALEN
Dosage Form : CAPSULE; ORAL
Application Number : 19926
Country : US
Patented : No
Drug : HYDROXYUREA
Dosage Form : CAPSULE; ORAL
Application Number : 213438
Country : US
Patented : No
Drug : PRAZOSIN HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 210971
Country : US
Patented : No
Drug : TEMOZOLOMIDE
Dosage Form : CAPSULE; ORAL
Application Number : 206309
Country : US
Patented : No
Drug : ZONISAMIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77637
Country : US
Patented : No
Drug : LOXAPINE SUCCINATE
Dosage Form : CAPSULE; ORAL
Application Number : 76762
Country : US
Patented : No
Drug : TEMOZOLOMIDE
Dosage Form : CAPSULE; ORAL
Application Number : 203898
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : HYDROXYZINE PAMOATE
Dosage Form : CAPSULE; ORAL
Application Number : 88487
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
